Skip to main content
Top

Drugs

Issue 14/2015

Content (11 Articles)

Escalation and De-escalation of Therapy in COPD: Myths, Realities and Perspectives

  • Current Opinion

Mario Cazzola, Paola Rogliani, Maria Gabriella Matera

Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics

  • Review Article

Sophie Marchal, Amélie El Hor, Marie Millard, Véronique Gillon, Lina Bezdetnaya

Current Strategies to Reduce Gastrointestinal Bleeding Risk Associated with Antiplatelet Agents

  • Review Article

Parth J. Parekh, Edward C. Oldfield IV, David A. Johnson

Roflumilast: A Review in COPD

  • Adis Drug Evaluation

Karly P. Garnock-Jones

Perampanel: A Review in Drug-Resistant Epilepsy

  • Adis Drug Evaluation

James E. Frampton

Eliglustat: A Review in Gaucher Disease Type 1

  • Adis Drug Evaluation

Lesley J. Scott

AFREZZA® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus

  • Adis Drug Evaluation

Esther S. Kim, Greg L. Plosker

Brexpiprazole: First Global Approval

  • AdisInsight Report

Sarah L. Greig

Alirocumab: First Global Approval

  • AdisInsight Report

Anthony Markham

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images